Page 21 - பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா இல் சான் பிரான்சிஸ்கோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா இல் சான் பிரான்சிஸ்கோ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா இல் சான் பிரான்சிஸ்கோ Today - Breaking & Trending Today

The controversial approval of an Alzheimer's drug reignites the battle over the underlying cause of the disease


The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease
Laurie McGinley
© Jessica Rinaldi/Pool/Via Reuters
Marc Archambault, who has early-stage Alzheimer s disease, receives his first dose Wednesday of the newly approved intravenous drug Aduhelm at Butler Hospital in Providence, R.I. (Jessica Rinaldi/Pool/Reuters)
Neurologist Matthew S. Schrag was surprised when he heard the Food and Drug Administration had approved a controversial Alzheimer’s drug. There was scant evidence the treatment worked, in his view.
Even more concerning to Schrag: the FDA’s apparent embrace of a long-debated theory about Alzheimer’s disease, which afflicts more than 6 million Americans. The amyloid hypothesis, which has dominated the field for decades, holds that toxic clumps in the brain, called amyloid beta, are the main driver of the disease and that removing them will slow cognitive decline. ....

University Of Southern California , United States , Rhode Island , Gil Rabinovici , Peter Stein , Dennis Gibbs , Janet Woodcock , Vanderbilt Schrag , Eli Lilly , Alfred Sandrock Jr , Marc Archambault , Matthews Schrag , Halima Amjad , Jason Karlawish , Paula Newhouse , Alois Alzheimer , Paul Aisen , Ri Jessica Rinaldi , Johns Hopkins University , Vanderbilt University Medical Center , Members Of Congress , Drug Administration , Drug Administration On , Office Of New Drugs , University Of California At San Francisco , University Of Pennsylvania ,